NEUWIRTH, Radek, Jakub CVEK, Lukas KNYBEL, Otakar JIRAVSKÝ, Lukas MOLENDA, Michal KODAJ, Martin FIALA, Petr PEICHL, David FELTL, Jaroslav JANUSKA, Jan HECKO a Josef KAUTZNER. Stereotactic radiosurgery for ablation of ventricular tachycardia. EP Europace. Oxford: Oxford University Press, 2019, roč. 21, č. 7, s. 1088-1095. ISSN 1099-5129. Dostupné z: https://dx.doi.org/10.1093/europace/euz133.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Stereotactic radiosurgery for ablation of ventricular tachycardia
Autoři NEUWIRTH, Radek (203 Česká republika, domácí), Jakub CVEK (203 Česká republika, garant), Lukas KNYBEL (203 Česká republika), Otakar JIRAVSKÝ (203 Česká republika), Lukas MOLENDA (203 Česká republika), Michal KODAJ (203 Česká republika), Martin FIALA (203 Česká republika, domácí), Petr PEICHL (203 Česká republika), David FELTL (203 Česká republika), Jaroslav JANUSKA (203 Česká republika), Jan HECKO (203 Česká republika) a Josef KAUTZNER (203 Česká republika).
Vydání EP Europace, Oxford, Oxford University Press, 2019, 1099-5129.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30201 Cardiac and Cardiovascular systems
Stát vydavatele Velká Británie a Severní Irsko
Utajení není předmětem státního či obchodního tajemství
WWW URL
Impakt faktor Impact factor: 4.045
Kód RIV RIV/00216224:14110/19:00112603
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.1093/europace/euz133
UT WoS 000493046000018
Klíčová slova anglicky Ventricular tachycardia; Stereotactic body radiotherapy; Ablation
Štítky 14110211, rivok
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Mgr. Tereza Miškechová, učo 341652. Změněno: 7. 1. 2021 14:47.
Anotace
Aims Stereotactic body radiotherapy (SBRT) for ventricular tachycardias (VTs) could be an option after failed catheter ablation. In this study, we analysed the long-term efficacy and toxicity of SBRT applied as a bail-out procedure. Methods and results Patients with structural heart disease and unsuccessful catheter ablations for VTs underwent SBRT. The planning target volume (PTV) was accurately delineated using exported 3D electroanatomical maps with the delineated critical part of re-entry circuits. This was defined by detailed electroanatomic mapping and by pacing manoeuvres during the procedure. Using the implantable cardioverter-defibrillator lead as a surrogate contrast marker for respiratory movement compensation, 25 Gy was delivered to the PTV using CyberKnife. We evaluated occurrences of sustained VT, electrical storm, antitachycardia pacing, and shock; time to death; and radiation-induced events. From 2014 until March 2017, 10 patients underwent radiosurgical ablation (mean PTV, 22.15 mL; treatment duration, 68 min). After radiosurgery, four patients experienced nausea and one patient presented gradual progression of mitral regurgitation. During the follow-up (median 28 months), VT burden was reduced by 87.5% compared with baseline (P = 0.012) and three patients suffered non-arrhythmic deaths. After the blanking period, VT recurred in eight of 10 patients. The mean time to first antitachycardia pacing and shock were 6.5 and 21 months, respectively. Conclusion Stereotactic body radiotherapy appears to show long-term safety and effectiveness for VT ablation in structural heart disease inaccessible to catheter ablation. We report one possible radiation-related toxicity and promising overall survival, warranting evaluation in a prospective multicentre clinical trial.
VytisknoutZobrazeno: 26. 4. 2024 16:56